It is a trading private limited company based in Cochin, Kerala, India, established in 2009.
2009 | Cochin, Kerala, India | Under Process Of Striking OffMax Uniorange Pharma (India) Private Limited, a under process of striking off private limited company, was established on 26 June 2009 in Cochin, Kerala, India. Engaging in other wholesale within the trade sector, it holds CIN: U24233KL2009PTC024373. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Thomas Varkey Padingare Chempanal (Whole-Time Director), Abdulrahim Aboobacker Pallimuttathe (Whole-Time Director), Vijayan Praveen (Whole-Time Director). Past directors included Raghunandan Govinda Menon, Putharadathu Narayanan Bhavanendranathan Nair, Rajeswar Dayal Chandrasekharan Nair. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 3/335 - K, 2Nd Floor, Jogeo Building P. T. Road, Kakkanad, Cochin, Kerala, 682021.
U24233KL2009PTC024373
024373
26 June 2009
₹1.50 M
₹1.00 M
Roc Ernakulam
Unlisted
Under Process Of Striking Off
Explore comprehensive insights into Max Uniorange Pharma (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Thomas Varkey Padingare Chempanal | Whole-Time Director | 26 Jun 2009 | Current |
| Abdulrahim Aboobacker Pallimuttathe | Whole-Time Director | 26 Jun 2009 | Current |
| Vijayan Praveen | Whole-Time Director | 26 Jun 2009 | Current |
| John Thottumkal Thomas | Whole-Time Director | 26 Jun 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Apr 2019 | Past |
| Pramod Abcsdd | Whole-Time Director | 12 Apr 2019 | Past |
| Pramod Abcsdd | Whole-Time Director | 12 Apr 2019 | Past |
| Pramod Abcsdd | Director | 25 Feb 2011 | Past |
| Pramod Abcsdd | Director | 25 Feb 2011 | Past |
| Pramod Abcsdd | Director | 25 Feb 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Max Uniorange Pharma (India) Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Max Uniorange Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Max Uniorange Pharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Max Uniorange Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Max Uniorange Pharma (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Max Uniorange Pharma (India) Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
The activity Max Uniorange Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ernakulam. was completed.
The activity Thomas Varkey Padingare Chempanal was appointed as a Whole-time director was appointed as a Whole-time director on 26 Jun 2009 & has been associated with this company since 16 years 5 months . was completed.
Progress on Abdulrahim Aboobacker Pallimuttathe was appointed as a Whole-time director was appointed as a Whole-time director on 26 Jun 2009 & has been associated with this company since 16 years 5 months . was documented.
The activity Vijayan Praveen was appointed as a Whole-time director was appointed as a Whole-time director on 26 Jun 2009 & has been associated with this company since 16 years 5 months . was completed.
The activity John Thottumkal Thomas was appointed as a Whole-time director was appointed as a Whole-time director on 26 Jun 2009 & has been associated with this company since 16 years 5 months . was completed.
The CIN of Max Uniorange Pharma (India) Private Limited is U24233KL2009PTC024373.
Max Uniorange Pharma (India) Private Limited is headquartered at 3/335 - K, 2Nd Floor, Jogeo Building P. T. Road, Kakkanad, Cochin, Kerala, 682021.
Max Uniorange Pharma (India) Private Limited was incorporated on 26 June 2009.
The current directors of Max Uniorange Pharma (India) Private Limited are
The primary industry of Max Uniorange Pharma (India) Private Limited is Trade.
Max Uniorange Pharma (India) Private Limited is unlisted.
The authorized capital of Max Uniorange Pharma (India) Private Limited is ₹1.50 M, and the paid-up capital is ₹1.00 M.
The compliance status of Max Uniorange Pharma (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX